Author Archives : Birgit Rogell

Home  >>  Author : Birgit Rogell

TRANSVAC: European Vaccine Research and Development Infrastructure

On Oktober 17, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für TRANSVAC: European Vaccine Research and Development Infrastructure

TRANSVAC is a new infrastructure project – funded by the European Commission in the context of Horizon 2020 – that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal  to build an efficient and sustainable collaboration of experts…

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

On Oktober 12, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups International Biotech Semifinal of the European Health Catapult Heidelberg, 12 October 2017 On October 4-6, BioRN, together with EIT Health, organized the Biotech Semifinal of the European Health Catapult. The Biotech semifinal consisted of two training days…

Roche: FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus

On Oktober 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: FDA approves Roche cobas Zika as first commercially-available donor screening test for Zika virus

Zika virus infection is linked to neurological complications in adults, and brain defects in fetuses and newborn infants cobas Zika complements efforts to prevent the spread of Zika virus through blood donations in the U.S. cobas Zika expands Roche’s industry-leading donor screening portfolio for blood-borne diseases Roche (SIX: RO, ROG;…

Merck Invests € 35 Million in its Italian Biotech Manufacturing Site of Bari

On Oktober 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck Invests € 35 Million in its Italian Biotech Manufacturing Site of Bari

New production line for the aseptic filling of biotech medicines under isolator Isolator technology represents best practice for the aseptic filling of injectable medicines and ensures the highest quality standards Investment supports growth of Merck’s portfolio of biotech medicines Bari, Italy, October 3, 2017 – Merck, a leading science and…

Leica Biosystems and Inspirata Sign Agreement to add Aperio Digital Pathology Scanners to Inspirata’s end-to-end Workflow Solution Portfolio

On Oktober 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Leica Biosystems and Inspirata Sign Agreement to add Aperio Digital Pathology Scanners to Inspirata’s end-to-end Workflow Solution Portfolio

Leica Biosystems suite of anatomic pathology whole slide scanners will be available as best-of-breed options for the diverse needs of the complex pathology departments served by Inspirata. Washington, DC, October 10, 2017/Globe Newswire – Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it has finalized…

EMBL alumnus Jacques Dubochet has been named as a co-recipient of the 2017 Nobel Prize in chemistry

On Oktober 11, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL alumnus Jacques Dubochet has been named as a co-recipient of the 2017 Nobel Prize in chemistry

EMBL alumnus Jacques Dubochet recognised for work at EMBL that led to birth of cryo-electron microscopy EMBL alumnus Jacques Dubochet has been named as a co-recipient of the 2017 Nobel Prize in chemistry for developing cryo-electron microscopy to determine the structure of the molecular building blocks of life in high-resolution….

EMBL: Looping the loops: How chromosomes form

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Looping the loops: How chromosomes form

EMBL researchers and collaborators take important steps in unravelling chromosome formation The nucleus of a human cell is less than one hundredth of a millimetre across but the DNA inside it – if stretched out – would be around two metres long. To fit into such a small space, the…

Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

Orphan designations facilitate the development and authorization of medicines for rare diseases, as assessed by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products  Heidelberg, Germany, October 05, 2017 – Apogenix AG, a biopharmaceutical company developing next-generation immuno-oncology therapeutics, announced today that its lead product candidate, asunercept (APG101), has…

PROGEN acquires EuroProxima’s research antibodies

On Oktober 9, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für PROGEN acquires EuroProxima’s research antibodies

PROGEN Biotechnik GmbH expands portfolio in the cell biology market Heidelberg, 05.10.2017 – PROGEN Biotechnik GmbH, established manufacturer of premium antibodies, has recently acquired the research antibody line of the Dutch company EuroProxima B.V., a global provider of immunobiological test systems. The deal encompasses about 190 products that supplement PROGEN’s…

Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

On Oktober 3, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Roche: Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams

Roche launches NAVIFY Tumor Board solution to provide decision support to oncology care teams The NAVIFY Tumor Board solution is a new, cloud-based software solution that fundamentally changes the way oncology care teams prepare for, conduct and document clinical treatment decisions for cancer patients It supports care team collaboration and…